The latest closing stock price for Viridian Therapeutics as of February 21, 2025 is 16.27.
An investor who bought $1,000 worth of Viridian Therapeutics stock at the IPO in 2014 would have $-992 today, roughly -1 times their original investment - a -35.56% compound annual growth rate over 11 years.
The all-time high Viridian Therapeutics stock closing price was 2045.25 on June 18, 2014.
The Viridian Therapeutics 52-week high stock price is 27.20, which is 67.2% above the current share price.
The Viridian Therapeutics 52-week low stock price is 11.40, which is 29.9% below the current share price.
The average Viridian Therapeutics stock price for the last 52 weeks is 17.57.
An investor who bought $1,000 worth of Viridian Therapeutics stock at the IPO in 2014 would have $-992 today, roughly -1 times their original investment - a -35.56% compound annual growth rate over 11 years.
The all-time high Viridian Therapeutics stock closing price was 2045.25 on June 18, 2014.
The Viridian Therapeutics 52-week high stock price is 27.20, which is 67.2% above the current share price.
The Viridian Therapeutics 52-week low stock price is 11.40, which is 29.9% below the current share price.
The average Viridian Therapeutics stock price for the last 52 weeks is 17.57.